Glucagon contributes to liver zonation.

Proc Natl Acad Sci U S A

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591

Published: April 2018

Liver zonation characterizes the separation of metabolic pathways along the lobules and is required for optimal function. Wnt/β-catenin signaling controls metabolic zonation by activating genes in the perivenous hepatocytes, while suppressing genes in the periportal counterparts. We now demonstrate that glucagon opposes the actions of Wnt/β-catenin signaling on gene expression and metabolic zonation pattern. The effects were more pronounced in the periportal hepatocytes where 28% of all genes were activated by glucagon and inhibited by Wnt/β-catenin. The glucagon and Wnt/β-catenin receptors and their signaling pathways are uniformly distributed in periportal and perivenous hepatocytes and the expression is not regulated by the opposing signal. Collectively, our results show that glucagon controls gene expression and metabolic zonation in the liver through a counterplay with the Wnt/β-catenin signaling pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924920PMC
http://dx.doi.org/10.1073/pnas.1721403115DOI Listing

Publication Analysis

Top Keywords

wnt/β-catenin signaling
12
metabolic zonation
12
liver zonation
8
zonation liver
8
perivenous hepatocytes
8
gene expression
8
expression metabolic
8
glucagon
5
zonation
5
wnt/β-catenin
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!